Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shoseyov, D.
Right arrow Articles by Kerem, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shoseyov, D.
Right arrow Articles by Kerem, E.
(Chest. 2006;130:222-226.)
© 2006 American College of Chest Physicians

Aspergillus Bronchitis in Cystic Fibrosis*

David Shoseyov, MD; Keith G. Brownlee, MBChB; Steven P. Conway, MBBS and Eitan Kerem, MD

* From the Department of Pediatrics and CF Center (Drs. Shoseyov and Kerem), Hadassah University Hospital, Mount Scopus, Jerusalem, Israel; and Paediatric and Adult Regional Cystic Fibrosis Centres (Drs. Brownlee and Conway), St James’ and Seacroft University Hospitals, Leeds, UK.

Correspondence to: Eitan Kerem, MD, Head, Department of Pediatrics and CF Center, Hadassah University Hospital, Mount Scopus, Jerusalem, Israel; e-mail: kerem{at}hadassah.org.il

Abstract

Aspergillus fumigatus, a widely distributed spore-bearing fungus, is commonly grown in sputum cultures of patients with cystic fibrosis (CF). A fumigatus may cause allergic bronchopulmonary aspergillosis (ABPA), a complex condition that leads to worsening of airway inflammation and progressive damage and is diagnosed by specific criteria. In this report, we present six CF patients with respiratory deterioration that did not respond to appropriate antibiotic treatment. All had had A fumigatus in sputum cultures but did not fulfill the criteria of ABPA. Treatment with antifungal agents was followed by improvement in clinical condition. We suggest that in patients with CF, A fumigatus should be considered as a pathogen that may directly cause respiratory exacerbations. Antifungal therapy should be considered when deteriorating respiratory function is not responding to antibacterial therapy and A fumigatus is growing in sputum cultures.

Key Words: allergic bronchopulmonary aspergillosis • antifungal therapy • Aspergillus fumigatus • cystic fibrosis







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American College of Chest Physicians.